Evaluation of the use of nab-paclitaxel and gemcitabine in clinical practice. [electronic resource]
Producer: 20181030Description: S730-S735 p. digitalISSN:- 1998-4138
- Aged
- Albumins -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Deoxycytidine -- adverse effects
- Disease-Free Survival
- Drug-Related Side Effects and Adverse Reactions -- classification
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Paclitaxel -- adverse effects
- Pancreatic Neoplasms -- drug therapy
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.